These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28692818)

  • 21. Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.
    Peffault de Latour R; Peters C; Gibson B; Strahm B; Lankester A; de Heredia CD; Longoni D; Fioredda F; Locatelli F; Yaniv I; Wachowiak J; Donadieu J; Lawitschka A; Bierings M; Wlodarski M; Corbacioglu S; Bonanomi S; Samarasinghe S; Leblanc T; Dufour C; Dalle JH; ;
    Bone Marrow Transplant; 2015 Sep; 50(9):1168-72. PubMed ID: 26052913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.
    Cooper JP; Farah RJ; Stevenson PA; Gooley TA; Storb R; Scott BL
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1331-1339. PubMed ID: 30711779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posttransplant complications in patients with marrow failure syndromes: are we improving long-term outcomes?
    Hudda Z; Myers KC
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):141-148. PubMed ID: 38066882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
    Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study.
    Soltermann Y; Heim D; Medinger M; Baldomero H; Halter JP; Gerull S; Arranto C; Passweg JR; Kleber M
    Ann Hematol; 2019 Jun; 98(6):1485-1493. PubMed ID: 30915500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Race and socioeconomic status in pediatric allogeneic hematopoietic cell transplantation for nonmalignant conditions.
    Harney SM; Kahn JM; Jin Z; Wong P; McKetta S; Satwani P
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28367. PubMed ID: 32497418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal intensity conditioning strategies for bone marrow failure: is it time for "preventative" transplants?
    Agarwal S
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):135-140. PubMed ID: 38066900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incident cancers and late mortality in Australian children treated by allogeneic stem cell transplantation for non-malignant diseases.
    Nelson AS; Vajdic CM; Ashton LJ; Le Marsney RE; Nivison-Smith I; Wilcox L; Dodds AJ; O'Brien TA;
    Pediatr Blood Cancer; 2017 Jan; 64(1):197-202. PubMed ID: 27671369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EBMT survey on bone marrow transplant activity in Europe: regional differences.
    Gratwohl A; Hermans J
    Bone Marrow Transplant; 1994 Jun; 13(6):683-8. PubMed ID: 7920292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced-intensity conditioning (RIC) in children with nonmalignant disorders (NMD) undergoing unrelated donor umbilical cord blood transplantation (UCBT).
    Parikh S; Szabolcs P
    Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S53-5. PubMed ID: 22226113
    [No Abstract]   [Full Text] [Related]  

  • 31. Hematopoietic stem cell transplantation in childhood: report from the bone marrow transplantation group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
    Pession A; Rondelli R; Paolucci P; Pastore G; Dini G; Bonetti F; Madon E; Mandelli F; Zanesco L; Uderzo C; Prete A; Rabusin M; Ugazio A; Di Bartolomeo P; Favre C; Bojd-Faulkner L; Poggi V; Luksch R; Donfrancesco A; Argiolu F; La Nasa G; Amici A; Locatelli F
    Haematologica; 2000 Jun; 85(6):638-46. PubMed ID: 10870122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of allogeneic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria with or without aplastic anemia.
    Lee SE; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Lee JW
    Eur J Haematol; 2017 Oct; 99(4):336-343. PubMed ID: 28675769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Primary immunodeficiency and inherited bone marrow failure syndrome in adults].
    Takada H
    Rinsho Ketsueki; 2018; 59(10):2204-2211. PubMed ID: 30305527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation.
    Pagliuca S; Peffault de Latour R; Volt F; Locatelli F; Zecca M; Dalle JH; Comoli P; Vettenranta K; Diaz MA; Reuven O; Bertrand Y; Diaz de Heredia C; Nagler A; Ghavamzadeh A; Sufliarska S; Lawson S; Kenzey C; Rocha V; Dufour C; Gluckman E; Passweg J; Ruggeri A
    Biol Blood Marrow Transplant; 2017 Nov; 23(11):1939-1948. PubMed ID: 28797779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation.
    Lin CJ; Vader JM; Slade M; DiPersio JF; Westervelt P; Romee R
    Cancer; 2017 May; 123(10):1800-1809. PubMed ID: 28262921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular diagnosis and hematopoietic stem cell transplantation in 17 children with inherited bone marrow failure syndrome].
    Li Q; Li B; Luo C; Wang J; Luo C; Ding L; Chen J
    Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):817-23. PubMed ID: 26758319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful reduced-intensity conditioning hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria with aplastic anemia in two children.
    Andolina JR; Reinish AL; Akhtar R; Noronha S; Shand JC; Girvin A; Korones DN; Bruckner LB; Mullen CA; Curran KJ; Boulad F
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27218. PubMed ID: 29722478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.
    Atsuta Y; Baldomero H; Neumann D; Sureda A; DeVos JD; Iida M; Karduss A; Purtill D; Elhaddad AM; Bazuaye NG; Bonfim C; De la Camara R; Chaudhri NA; Ciceri F; Correa C; Frutos C; Galeano S; Garderet L; Gonzalez-Ramella O; Greco R; Hamad N; Hazenberg MD; Horowitz MM; Kalwak K; Ko BS; Kodera Y; Koh MB; Liu K; McLornan DP; Moon JH; Neven B; Okamoto S; Pasquini MC; Passweg JR; Paulson K; Rondelli D; Ruggeri A; Seber A; Snowden JA; Srivastava A; Szer J; Weisdorf D; Worel N; Greinix H; Saber W; Aljurf M; Niederwieser D
    Haematologica; 2024 Oct; 109(10):3282-3294. PubMed ID: 38721749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inherited bone marrow failure syndrome: management and diagnostic advances utilizing next-generation sequencing].
    Muramatsu H
    Rinsho Ketsueki; 2018; 59(6):716-722. PubMed ID: 29973450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.